AB
CSTL icon

Amalgamated Bank’s Castle Biosciences CSTL Stock Holding History

Amalgamated Bank’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-892
Closed -$35K – 1912
2025
Q4 		$35K Sell
892
-1
-0.1% -$32 ﹤0.01% 1927
2025
Q3 		$20K Hold
893
– – ﹤0.01% 2116
2025
Q2 		$18K Hold
893
– – ﹤0.01% 2146
2025
Q1 		$18K Buy
893
+60
+7% +$1.49K ﹤0.01% 2088
2024
Q4 		$22K Hold
833
– – ﹤0.01% 2080
2024
Q3 		$24K Hold
833
– – ﹤0.01% 2056
2024
Q2 		$18K Hold
833
– – ﹤0.01% 2160
2024
Q1 		$18K Sell
833
-1,850
-69% -$40.2K ﹤0.01% 2164
2023
Q4 		$58K Sell
2,683
-248
-8% -$4.37K ﹤0.01% 2181
2023
Q3 		$50K Hold
2,931
– – ﹤0.01% 2249
2023
Q2 		$40K Buy
2,931
+416
+17% +$8.43K ﹤0.01% 2409
2023
Q1 		$57K Sell
2,515
-599
-19% -$14.6K ﹤0.01% 2255
2022
Q4 		$73K Hold
3,114
– – ﹤0.01% 2266
2022
Q3 		$81K Buy
3,114
+92
+3% +$2.58K ﹤0.01% 2246
2022
Q2 		$66K Sell
3,022
-375
-11% -$8.71K ﹤0.01% 2343
2022
Q1 		$152K Buy
+3,397
New +$140K ﹤0.01% 2041
2021
Q4 		– Sell
-3,709
Closed -$247K – 2165
2021
Q3 		$247K Sell
3,709
-231
-6% -$16.3K ﹤0.01% 1916
2021
Q2 		$289K Buy
+3,940
New +$260K ﹤0.01% 1904

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Amalgamated Bank's CSTL Position: Q1 2026 in Review

Amalgamated Bank sold out of Castle Biosciences (CSTL) in Q1 2026, closing a stake of 892 shares — an estimated $35K sold.

Amalgamated Bank first reported a position in CSTL in Q2 2021 and held it in 18 quarters. The position peaked at $289K in Q2 2021. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • Amalgamated Bank reported no remaining Castle Biosciences position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 892 Castle Biosciences shares in Q1 2026, an estimated $35K.
  • Amalgamated Bank first reported a position in Castle Biosciences in Q2 2021 and held it in 18 quarters.
  • Amalgamated Bank's Castle Biosciences position peaked at $289K in Q2 2021.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.